Skip to main content

CANGENE BIOPHARMA LLC is a medicinal and botanical manufacturing employer in BALTIMORE, MD. Federal records show 1 OSHA inspection with 0 violations and $0 in penalties. All data sourced from public federal enforcement records.

Data sourced from OSHA, DOL WHD, MSHA, EPA ECHO, NLRB, FMCSA, OFLC, BLS, SAM.gov, CMS, USAspending, CPSC, NHTSA, and the UVA Corporate Prosecution Registry. Last updated: May 3, 2026.

CANGENE BIOPHARMA LLC

1111 S. PACA STREET, BALTIMORE, MD, 21230

Parent: Emergent BioSolutions Inc. (1,816 locations)

325411 Top companies in Medicinal and Botanical Manufacturing

EIN: 521176514

380 employees

Federal Enforcement
1
OSHA inspection

Industry Benchmark

Industry Avg TRIR
1.4
Industry Avg DART
1
Self-Reported DART
1.0
Self-Reported TRIR
1.3
Industry rates from BLS SOII 2024. Self-reported rates from OSHA ITA Form 300A (employer self-reported).
OSHA Inspections
1
OSHA Violations
0
Total Penalties
$0
Trend
STABLE
WHD Cases
0
Back Wages Owed
$0
Confidence
MEDIUM
SVEP Flag
No

Data Insights

History Span
6 years
Last Activity
6yr ago
Inspection Rate
0.2/yr
TRIR vs Industry Avg
-0.1
Below industry average
DART vs Industry Avg
0
Below industry average

Inspection Breakdown

Complaint
1
Complaint and accident-triggered inspections are stronger risk signals than routine planned inspections.

Need API access, CSV upload, or PDF reports? Upgrade to Paid for $79/mo.

Inspection History

No inspection records found.

Loading news...

The FastDOL Report

Weekly workplace compliance news. Free.

Data aggregated from public federal enforcement and program records (OSHA, WHD, MSHA, EPA, NLRB, FMCSA, OFLC, BLS, SAM.gov, CMS, USAspending, CPSC, NHTSA) plus the UVA Corporate Prosecution Registry. Employer profiles matched by name and location — matching errors may occur. Risk scores computed by FastDOL, not official government assessments. OSHA citations typically appear 3-8 months after the inspection, so very recent enforcement actions may not yet be reflected. Data provided as-is. Report a data error.

Part of a larger organization

CANGENE BIOPHARMA LLC is one of 1,816 establishments in our dataset that roll up under the parent organization Emergent BioSolutions Inc.. Emergent BioSolutions Inc. is a SEC public reporter (EBS), with most recent reported revenue of $743M.

Federal enforcement records on CANGENE BIOPHARMA LLC represent activity at this specific establishment. The full enforcement footprint of Emergent BioSolutions Inc. across all 1,816 of its tracked locations is viewable on the parent profile.

Other establishments operated by Emergent BioSolutions Inc.

Other employers in Medicinal and Botanical Manufacturing within MD

Industry context

The Bureau of Labor Statistics reports an industry-average Total Recordable Incident Rate (TRIR) of 1.4 for the medicinal and botanical manufacturing sector, with a Days Away, Restricted, or Transferred (DART) rate of 1. CANGENE BIOPHARMA LLC's self-reported DART rate is 1, which is below the industry average.

Activity timeline

No federal enforcement activity has been recorded against this establishment in the past 7 years.

Frequently Asked Questions

What is CANGENE BIOPHARMA LLC's OSHA violation history?
CANGENE BIOPHARMA LLC has 1 OSHA inspection on record with 0 violations and $0 in total penalties.
How does CANGENE BIOPHARMA LLC's safety record compare to its industry?
CANGENE BIOPHARMA LLC operates in the medicinal and botanical manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. CANGENE BIOPHARMA LLC's self-reported DART rate is 1 compared to an industry average of 1.

About this data

This profile aggregates federal enforcement records on CANGENE BIOPHARMA LLC of BALTIMORE, MD from 17 federal data sources. Records were found in 3 sources: OSHA workplace safety inspections, SEC XBRL companyfacts (parent financials), and BLS industry safety benchmarks. The remaining 14 sources were checked and found no matching records: WHD, MSHA, EPA, NLRB, OFLC, OFCCP, FMCSA, USAspending, SAM.gov, CMS, CPSC, NHTSA, UVA, SEC enforcement.

Establishments are matched across agencies using normalized employer name, state, and ZIP code. The dataset was last refreshed on May 3, 2026. CANGENE BIOPHARMA LLC resolves to the parent rollup Emergent BioSolutions Inc., which operates 1,816 establishments in our dataset.

This profile may be incomplete if CANGENE BIOPHARMA LLCoperates under multiple legal names, files under variations our entity-matching rules don't yet cover, or maintains records below current matching thresholds. To report a missing record or correction, email corrections@fastdol.com.